Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
Zhonghua Yi Xue Za Zhi
|
March 14, 2022
[Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph<sup>+</sup>acute B-lymphoblastic leukemia]
Y Tian, H Ai, X Ji, et al.
Zhonghua Yi Xue Za Zhi
|
January 24, 2019
[Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography]
Q C Meng, P R Gao, P F Ren, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 14, 2020
[Efficacy of nilotinib in the first-line treatment of chronic myeloid leukemia and the analysis of factors affecting molecular responses]
L Y Chen, Z Li, Yanli Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
April 11, 2022
[Analysis of clinical significance and prognostic impact of TET2 single nucleotide polymorphism I1762V in patients with acute myeloid leukemia]
Y W Li, Z Guo, L L Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 30, 2018
[Haploid hematopoietic stem cell transplantation in the treatment of Ph chromosome positive mixed phenotype acute leukemia: report of two cases with literature review]
T T Li, H Ai, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
April 22, 2020
[Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation]
H Ai, Q S Yin, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 21, 2019
[Donor HSCs with a preexisting ASXL1-mutation evoluting FLT3-ITD positive AML-M<sub>2</sub> and FLT3-ITD negative AML-M<sub>5</sub> in the donor and recipient respectively: one case analysis and literatures review]
D Kong, K Sun, M Y Shi, et al.
Technology in Cancer Research & Treatment
|
January 11, 2011
Phase I/II study of hypofractioned radiation with three-dimensional conformal radiotherapy for clinical T3-4N0-1M0 stage esophageal carcinoma
Y-P Song, J-B Ma, L-K Hu, et al.
Zhonghua Nei Ke Za Zhi
|
July 31, 2018
[The clinical safety and efficacy of low dose rituximab regimen on patients with Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation]
H Ai, Y W Fu, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 22, 2018
[Human cytomegalovirus pneumonia and intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a case report and literatures review]
L N Zhang, M H Li, J Zhou, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
Zhonghua Yi Xue Za Zhi
|
March 14, 2022
[Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph<sup>+</sup>acute B-lymphoblastic leukemia]
Y Tian, H Ai, X Ji, et al.
Zhonghua Yi Xue Za Zhi
|
January 24, 2019
[Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography]
Q C Meng, P R Gao, P F Ren, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 14, 2020
[Efficacy of nilotinib in the first-line treatment of chronic myeloid leukemia and the analysis of factors affecting molecular responses]
L Y Chen, Z Li, Yanli Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
April 11, 2022
[Analysis of clinical significance and prognostic impact of TET2 single nucleotide polymorphism I1762V in patients with acute myeloid leukemia]
Y W Li, Z Guo, L L Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 30, 2018
[Haploid hematopoietic stem cell transplantation in the treatment of Ph chromosome positive mixed phenotype acute leukemia: report of two cases with literature review]
T T Li, H Ai, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
April 22, 2020
[Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation]
H Ai, Q S Yin, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 21, 2019
[Donor HSCs with a preexisting ASXL1-mutation evoluting FLT3-ITD positive AML-M<sub>2</sub> and FLT3-ITD negative AML-M<sub>5</sub> in the donor and recipient respectively: one case analysis and literatures review]
D Kong, K Sun, M Y Shi, et al.
Technology in Cancer Research & Treatment
|
January 11, 2011
Phase I/II study of hypofractioned radiation with three-dimensional conformal radiotherapy for clinical T3-4N0-1M0 stage esophageal carcinoma
Y-P Song, J-B Ma, L-K Hu, et al.
Zhonghua Nei Ke Za Zhi
|
July 31, 2018
[The clinical safety and efficacy of low dose rituximab regimen on patients with Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation]
H Ai, Y W Fu, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 22, 2018
[Human cytomegalovirus pneumonia and intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a case report and literatures review]
L N Zhang, M H Li, J Zhou, et al.
Page
of 14